Harvard Bioscience (HBIO) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.50 -2.4%
Financial Fact:
Total operating expenses: 12.5M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Total operating expenses: 12.5M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q3 EPS of $0.03, $0.02 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $25.7 million versus the consensus estimate of $27.01 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- L3Harris CEO steps down amid conduct review, shares drop
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
